Mental health · Allentown, PA
Mental health studies in Allentown, PA
6 recruiting studies have a site in Allentown.
6 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingPhase 2
A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression
Draig Therapeutics Ltd
- Location
- Allentown, PA + 19 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 2
A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)
Seaport Therapeutics
- Location
- Allentown, PA + 26 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingPhase 2
Study of ITI-1284 as an Adjunctive Treatment in Patients With Generalized Anxiety Disorder
Intra-Cellular Therapies, Inc.
- Location
- Allentown, PA + 24 other US sites
- Eligibility basics
- Any age listed
- RecruitingPhase 2
Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
Syndeio Biosciences, Inc
- Location
- Allentown, PA + 20 other US sites
- Eligibility basics
- Ages 18–64
- RecruitingPhase 2
Study to Assess Adverse Events and Change in Disease Activity When Oral ABBV-932 is Added to Antidepressant Therapies in Adult Participants With Generalized Anxiety Disorder
AbbVie
- Location
- Allentown, PA + 46 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingPhase 2
Study of ALTO-300 in MDD
Alto Neuroscience
- Location
- Allentown, PA + 36 other US sites
- Eligibility basics
- Ages 18–70
Who these studies look for
Studies usually require a confirmed diagnosis and stable circumstances, and they monitor safety closely. If you are in crisis, contact a crisis line or emergency services rather than a study.
Matching a page like this one never means you qualify. Each research team decides eligibility at screening.